Inovio Pharmaceuticals, Inc. (INO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 81.58M |
| Enterprise Value | 46.68M |
| P/E Ratio | -0.4 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 7.71 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.23 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.71 |
| Return On Equity | -6.66 |
| Revenue | 65,343 |
| Revenue/Share | 0 |
| Gross Profit | 65,343 |
| EBITDA | -81.96M |
| Net Income | -84.95M |
| Diluted EPS | -1.81 |
| Total Cash | 37.68M |
| Total Cash/Share | 0.55 |
| Total Debt | 8.7M |
| Total Debt/Equity | 1.43 |
| Current Ratio | 1.04 |
| Book Value Per Share | 0.09 |
| 52-Week Change | -52.66 |
| 52-Week High | 2.98 |
| 52-Week Low | 0.56 |
| Moving Average 50 Days | 1.13 |
| Moving Average 200 Days | 1.58 |
| Average Volume | 3.06M |
| Shares Outstanding | 53.59M |
| % Held by Institutions | 4.54 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | January 25, 2024 |